Glioblastoma is a aggressive brain cancer known for its rapid growth and resistance to typical treatments. Research are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for GBM treatment. LCA168 is a … Read More